STOCK TITAN

SOPH (NASDAQ) Rule 144 notice lists 684 restricted stock units and 10b5-1 sales

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

SOPH submitted a Rule 144 notice for the proposed sale of 684 restricted stock units by the issuer, dated 02/18/2026. The filing also lists prior 10b5-1 sales by Daan Guido Maria Van Well on 12/19/2025, 01/05/2026, 01/06/2026, and 01/20/2026, each showing quantities of 2051, 2056, or 684 shares in the excerpt.

Positive

  • None.

Negative

  • None.

Insights

Rule 144 notice lists a small issuer sale and recent 10b5-1 transactions.

The excerpt shows a Rule 144 filing for 684 restricted stock units with an issuer-designated sale date of 02/18/2026. Rule 144 filings notify the market of intended sales under resale exemptions and do not by themselves effect a transfer.

Examples of prior scheduled sales by Daan Guido Maria Van Well are listed on 12/19/2025, 01/05/2026, 01/06/2026, and 01/20/2026; the filing does not state cash proceeds or settlement details.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the SOPH Form 144 filing report?

The filing reports a proposed sale of 684 restricted stock units dated 02/18/2026. It also lists prior 10b5-1 sales by an affiliated holder on specific dates shown in the excerpt.

Who is listed as the selling party in the excerpt for SOPH?

The excerpt lists Daan Guido Maria Van Well as the reporting party for several 10b5-1 sales. The issuer line names Morgan Stanley Smith Barney LLC as the executing broker in the excerpt.

Do the listed 10b5-1 entries include sale quantities and dates?

Yes. The excerpt shows sale dates 12/19/2025, 01/05/2026, 01/06/2026, and 01/20/2026 with per-entry quantities such as 2051, 2056, or 684 as shown.

Does the Form 144 disclose proceeds or settlement details for SOPH?

The provided excerpt does not state cash proceeds or settlement terms. The filing lists share counts and dates but does not include dollar proceeds in the visible content.

Is the sale in the filing an issuer sale or a resale by a holder?

The summary line identifies the securities as Restricted Stock Units with the issuer listed; separate rows show prior 10b5-1 sales by a holder. The excerpt mixes issuer-designated and holder-sale entries as presented.
Sophia Genetics Sa

NASDAQ:SOPH

SOPH Rankings

SOPH Latest News

SOPH Latest SEC Filings

SOPH Stock Data

328.38M
63.48M
Health Information Services
Healthcare
Link
Switzerland
Rolle